Showing results (81-90 of 203) with videos related to
Sort By:
Pageof 21
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 30, 2008
Absorption, metabolism, and excretion of paliperidone, a new monoaminergic antagonist, in humansMarc Vermeir, Ineke Naessens, Bart Remmerie, et al.The AAPS Journal|March 16, 2019
A Receiver Operating Characteristic Framework for Non-adherence Detection Using Drug Concentration Thresholds-Application to Simulated Risperidone Data in Schizophrenic PatientsCarlos Pérez-Ruixo, Bart Remmerie, Juan José Peréz-Ruixo, et al.Blood|May 18, 2011
Antithrombotic drug candidate ALX-0081 shows superior preclinical efficacy and safety compared with currently marketed antiplatelet drugsHans Ulrichts, Karen Silence, Anne Schoolmeester, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 24, 2005
Mixed-effects modelling of the interspecies pharmacokinetic scaling of pegylated human erythropoietinKoen Jolling, Juan Jose Perez Ruixo, Alex Hemeryck, et al.Pharmaceutics|September 28, 2023
Predicting Volume of Distribution in Neonates: Performance of Physiologically Based Pharmacokinetic ModellingPieter-Jan De Sutter, Phebe Rossignol, Lien Breëns, et al.CPT: Pharmacometrics & Systems Pharmacology|March 24, 2024
Model-based meta-analysis to quantify the effects of short interfering RNA therapeutics on hepatitis B surface antigen turnover in hepatitis B-infected miceLouis Sandra, Huybrecht T'jollyn, An Vermeulen, et al.Journal of Pharmaceutical and Biomedical Analysis|October 28, 2017
A dried blood spot assay for paclitaxel and its metabolitesFeifan Xie, Elien De Thaye, An Vermeulen, et al.CPT: Pharmacometrics & Systems Pharmacology|July 23, 2021
Multiscale model of hepatitis C virus dynamics in plasma and liver following combination therapyXavier Woot de Trixhe, Wojciech Krzyzanski, An Vermeulen, et al.Journal of Clinical Pharmacology|January 9, 2010
Modeling the effectiveness of paliperidone ER and olanzapine in schizophrenia: meta-analysis of 3 randomized, controlled clinical trialsIgnacio Ortega, Juan Jose Perez-Ruixo, Kim Stuyckens, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 13, 2016
The Absolute Bioavailability and Effect of Food on the Pharmacokinetics of Odanacatib: A Stable-Label i.v./Oral Study in Healthy Postmenopausal WomenStefan Zajic, Stefaan Rossenu, David Hreniuk, et al.Pageof 21